Fmoc-Leu-OPfp

Fmoc-Leu-OPfp is an Fmoc-protected leucine pentafluorophenyl ester (OPfp), functioning as a chiral amino acid derivative where the stereogenic center of leucine is retained and the carboxyl group is activated as a pentafluorophenyl ester. The molecule combines a base-labile Fmoc carbamate on the alpha-amino functionality with a highly electrophilic OPfp ester that can participate in acyl transfer reactions under peptide-coupling conditions. The pentafluorophenyl leaving group enhances reactivity toward nucleophiles such as amines, while the hydrophobic isobutyl side chain of leucine provides characteristic steric and partitioning behavior for downstream peptide and peptidomimetic structures. The orthogonal pairing of an Fmoc-protected amine with an activated carboxylate makes Fmoc-Leu-OPfp a practical intermediate for controlled peptide assembly and for preparing leucine-containing fragments with defined N- and C-reactivity profiles.

1. Peptide Synthesis

Fmoc-Leu-OPfp supports solid-phase and solution-phase peptide construction by pairing an Fmoc-protected alpha-amino group with a carboxyl group activated as an OPfp ester for amide bond formation. The Fmoc group enables stepwise N-terminal protection and deprotection strategies, while the OPfp ester can react with incoming amines to install leucine as a C-terminal residue in a coupling sequence. The retained leucine stereochemistry helps maintain the expected conformational preferences of peptide backbones and side-chain packing. Leucine incorporation via this activated ester format can be applied to generate peptide building blocks, sequence-defined fragments, and research-grade peptide analogs used in biochemical assays and synthetic methodology development.

2. Protected Amino Acid Chemistry

Fmoc-Leu-OPfp functions as a protected amino acid derivative in which orthogonal functional-group handling separates N-protection (Fmoc) from C-activation (OPfp). The alpha-amino functionality is masked as an Fmoc carbamate, enabling selective deprotection without directly disturbing the activated ester during controlled coupling workflows. The OPfp moiety provides a reactive acyl handle for derivatization, allowing conversion into amide-linked products while the Fmoc group remains compatible with common peptide synthesis protecting-group strategies. Downstream synthetic utility includes preparing leucine-containing intermediates for fragment coupling, generating defined C-terminal leucine amides, and supplying chiral building blocks for larger peptide and peptidomimetic assemblies.

3. Peptidomimetics And SAR Studies

Fmoc-Leu-OPfp can be employed in peptidomimetic construction and structure-activity relationship studies where leucine-bearing motifs require controlled stereochemistry and reliable amide formation. The hydrophobic leucine side chain, combined with an Fmoc-controlled N-terminus and an OPfp-activated carboxylate, supports the synthesis of analog libraries featuring modified linkers, constrained backbones, or substituted terminal groups. The activated ester format facilitates incorporation of leucine into diverse scaffolds by reacting with appropriately protected nucleophiles, enabling parallel generation of structure-defined compounds for SAR investigations. Synthetic routes can therefore use Fmoc-Leu-OPfp as a chiral intermediate to build leucine-containing fragments that feed into downstream profiling workflows.

4. Chemical Manufacturing Intermediates

Fmoc-Leu-OPfp is suitable for process chemistry intermediate preparation where activated amino acid esters are used to streamline coupling steps in fine chemical production. The OPfp ester provides a defined electrophilic carboxyl functionality that can be consumed in controlled acylation operations, while the Fmoc group provides a stable N-protection handle during intermediate handling and purification. The combination of chiral leucine architecture with orthogonal protecting-group behavior can support scalable manufacturing of protected peptide fragments and leucine-terminated intermediates for industrial peptide ingredient workflows. The resulting downstream materials can be converted into larger peptide constructs or used as standardized building blocks for specialty chemical production requiring reproducible stereochemical identity.

5. Analytical Research Standards

Fmoc-Leu-OPfp can serve analytical research by providing a defined Fmoc- and OPfp-bearing leucine species that maps to common detection and monitoring strategies in peptide synthesis workflows. The presence of the pentafluorophenyl ester can aid mass spectrometric identification and differentiation of activated intermediates during process development and reaction monitoring. The Fmoc chromophore and the leucine side-chain signature enable traceable tracking of N-protection state and residue incorporation in synthetic sequences. Analytical use can extend to method development for quantifying coupling intermediates, validating protecting-group behavior, and supporting impurity profiling in amino acid derivative manufacturing and peptide building block preparation.

1. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

2. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors

3. High fat diet and GLP-1 drugs induce pancreatic injury in mice

4. Uncarboxylated osteocalcin decreases insulin-stimulated glucose uptake without affecting insulin signaling and regulators of mitochondrial biogenesis in myotubes

5. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate